miRNA Profiling of Exosomes from Spontaneous Hypertensive Rats Using Next-Generation Sequencing

被引:0
|
作者
Xiaoyan Liu
Wen Yuan
Lei Yang
Jing Li
Jun Cai
机构
[1] Capital Medical University,Medical Research Center, Beijing Chaoyang Hospital
[2] Capital Medical University,Heart Center & Beijing Key Laboratory of Hypertension Research, Beijing Chaoyang Hospital
[3] Chinese Academy of Medical Sciences and Peking Union Medical College,Hypertension Center of Fuwai Hospital, State Key Laboratory of Cardiovascular Disease of China, National Center for Cardiovascular Diseases of China
关键词
Exosomes; Hypertension; miRNA;
D O I
暂无
中图分类号
学科分类号
摘要
The role and miRNA expression profile of exosomes in hypertension remain largely unknown. Therefore, next-generation sequencing was used to define the miRNA expression profile of plasma exosomes in spontaneously hypertensive rats (SHRs), the most widely used animal model of human essential hypertension, and their controls, normotensive Wistar-Kyoto rats (WKYs). Results revealed that percentages of miRNA in the total small RNA isolated from SHRs and WKYs were not significantly different. Twenty-seven miRNAs were significantly differentially expressed (DE) between SHR and WKY exosomes, including 23 up-regulated and four down-regulated in SHR exosomes as compared to WKY exosomes. Gene Ontology analysis and Kyoto Encyclopedia of Genes and Genomes pathway analysis of top 10 DE miRNAs identified hypertension-specific target genes/signaling pathways. In conclusion, our findings indicated the selective packing of miRNA cargo into exosomes under hypertensive status, which could facilitate the development of potential targets for the diagnosis, prevention, and treatment of hypertension.
引用
下载
收藏
页码:75 / 83
页数:8
相关论文
共 50 条
  • [41] Next-generation sequencing
    Jorge S Reis-Filho
    Breast Cancer Research, 11
  • [42] Next-generation sequencing
    Reis-Filho, Jorge S.
    BREAST CANCER RESEARCH, 2009, 11
  • [44] Targeted Next-Generation Sequencing for Comprehensive Genetic Profiling of Pharmacogenes
    Han, S. M.
    Park, J.
    Lee, J. H.
    Lee, S. S.
    Kim, H.
    Han, H.
    Kim, Y.
    Yi, S.
    Cho, J-Y
    Jang, I-J
    Lee, M. G.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2017, 101 (03) : 396 - 405
  • [45] Genomic Profiling of the Craniofacial Ossifying Fibroma by Next-Generation Sequencing
    Bahceci, Dorukhan H. H.
    Grenert, James P. P.
    Jordan, Richard C. K.
    Horvai, Andrew E. E.
    HEAD & NECK PATHOLOGY, 2023, 17 (03): : 722 - 730
  • [46] Genomic Profiling of the Craniofacial Ossifying Fibroma by Next-Generation Sequencing
    Dorukhan H. Bahceci
    James P. Grenert
    Richard C. K. Jordan
    Andrew E. Horvai
    Head and Neck Pathology, 2023, 17 : 722 - 730
  • [47] Current and future molecular profiling of cancer by next-generation sequencing
    Shibata, Tatsuhiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (10) : 895 - 899
  • [48] Urine microRNA profiling in bladder cancer by next-generation sequencing
    Pardini, Barbara
    Cordero, Francesca
    Naccarati, Alessio
    Ferrero, Giulio
    Viberti, Clara
    Oderda, Marco
    Arigoni, Maddalena
    Calogero, Raffaele
    Sacerdote, Carlotta
    Gontero, Paolo
    Vineis, Paolo
    Matullo, Giuseppe
    CANCER RESEARCH, 2017, 77
  • [49] Next-generation tag sequencing for cancer gene expression profiling
    Morrissy, A. Sorana
    Morin, Ryan D.
    Delaney, Allen
    Zeng, Thomas
    McDonald, Helen
    Jones, Steven
    Zhao, Yongjun
    Hirst, Martin
    Marra, Marco A.
    GENOME RESEARCH, 2009, 19 (10) : 1825 - 1835
  • [50] Molecular profiling in cholangiocarcinoma: A practical guide to next-generation sequencing
    Stenzinger, Albrecht
    Vogel, Arndt
    Lehmann, Ulrich
    Lamarca, Angela
    Hofman, Paul
    Terracciano, Luigi
    Normanno, Nicola
    CANCER TREATMENT REVIEWS, 2024, 122